Th2 cytokine response in Major Depressive Disorder patients before treatment

Journal of Neuroimmunology

Volumn 172, Issue 1-2, 2006, Pages 156-165

  Pavón, Lenin ^a   Sandoval López, Gabriel ^a   Eugenia Hernández, María ^a   Loría, Frida ^a   Estrada, Iris ^b   Pérez, Mayra ^b   Moreno, Julia ^a   Ávila, Ulises ^a   Leff, Philippe ^a   Antón, Benito ^a   Heinze, Gerhard ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Cortisol; Cytokines; Major Depressive Disorder; Psychoneuroimmunology; Th2 immune response

Indexed keywords

GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; B LYMPHOCYTE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; IMMUNOCOMPETENT CELL; MAJOR DEPRESSION; MALE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CYTOKINES; DEPRESSIVE DISORDER, MAJOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; RADIOIMMUNOASSAY; STATISTICS; TH2 CELLS;

EID: 33244495502     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.08.014     Document Type: Article

References (67)

1. W.H. Alwan, W.J. Kozlowska, and P.J. Openshaw Distinct types of lung disease caused by functional subsets of antiviral T cells J. Exp. Med. 179 1994 81 89
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4Th ed. 1994 American Psychiatric Press Washington, DC
3. A.V. Andreoli, S.E. Keller, M. Rabaeus, P. Marin, J.A. Bartlett, and C. Taban Depression and immunity: age, severity, and clinical course Brain Behav. Immun. 7 1993 279 292
4. H. Anisman, and Z. Merali Cytokines, stress and depressive illness: brain-immune interactions Ann. Med. 35 2003 2 11
5. H. Anisman, Z. Merali, M.O. Poulter, and S. Hayley Cytokines as a precipitant of depressive illness: animal and human studies Curr. Pharm. Des. 11 2005 963 972
6. H.O. Besedovsky, and A. Del Rey Immune-neuro-endocrine interactions: facts and hypotheses Endocr. Rev. 17 1996 64 102
7. J.E. Blalock The immune system as a sensory organ J. Immunol. 132 1984 1067 1070
8. F. Brambilla, and M. Maggioni Blood levels of cytokines in elderly patients with major depressive disorder Acta Psychiatr. Scand. 97 1998 309 313
9. M.N. Breunis, R.W. Kupka, and W.A. Nolen High numbers of circulating activated T cells and raised levels of serum IL-2 receptor in bipolar disorder Biol. Psychiatry 53 2003 157 165
10. S. Capellino, P. Montagna, B. Villaggio, and M. Cutolo Effects of estrogen peripheral metabolism in rheumatoid arthritis Reumatismo 57 2005 78 82
11. T.J. Connor, and B.E. Leonard Depression, stress and immunological activation: the role of cytokines in depressive disorders Life Sci. 62 1998 583 606
12. C.J. Cook Glucocorticoid feedback increases the sensitivity of the limbic system to stress Physiol. Behav. 75 2002 455 464
13. L. Cosmi, F. Liotta, R. Angeli, R. Mazzinghi, V. Santarlasci, R. Manetti, L. Lasagni, V. Vanini, P. Romagnani, E. Maggi, F. Annunziato, and S. Romagnani Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines Blood 103 2004 3117 3121
14. E.R. De Kloet Hormones, brain and stress Endocr. Regul. 37 2003 51 68
15. E.R. De Kloet, M. Joels, and F. Holsboer Stress and the brain: from adaptation to disease Nat. Rev., Neurosci. 6 2005 463 475
16. G. Del Prete Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy Allergy 47 1992 450 455
17. D.L. Evans, C.A. Pedersen, and J.D. Folds Major depression and immunity: preliminary evidence of decreased natural killer cell populations Prog. Neuro-Psychopharmacol. Biol. Psychiatry 12 1988 739 748
18. J.M. Grzych, E. Pearce, A. Cheever, Z.A. Caulada, P. Caspar, S. Heiny, F. Lewis, and A. Sher Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni J. Immunol. 146 1991 1322 1327
19. M. Haack, D. Hinze-Selch, T. Fenzel, T. Kraus, M. Kuhn, A. Schuld, and T. Pollmacher Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis J. Psychiatr. Res. 33 1999 407 418
20. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatr. 23 1960 56 62
21. Heinze, G., M.I.N.I 5.0.0., 2000. Mini International Neuropsychiatric Interview. Spanish South and Central America version/ DSM-IV. Sheehan DV and Lecrubier Y.
22. J.P. Herman, and W.E. Cullinan Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis Trends Neurosci. 20 1997 78 84
23. K.A. Hestad, S. Tonseth, C.D. Stoen, T. Ueland, and P. Aukrust Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy J. ECT 19 2003 183 188
24. H. Jozuka, E. Jozuka, S. Takeuchi, and O. Nishikaze Comparison of immunological and endocrinological markers associated with major depression J. Int. Med. Res. 31 2003 36 41
25. K.W. Kelley, R.M. Bluthe, R. Dantzer, J.H. Zhou, W.H. Shen, R.W. Johnson, and S.R. Broussard Cytokine-induced sickness behavior Brain Behav. Immun. 17 2003 S112 S118
26. G. Kenis, and M. Maes Effects of antidepressants on the production of cytokines Int. J. Neuropsychopharmacol. 5 2002 401 412
27. D. Keppler, and K. Decker H.U. Bergmeyer J. Bergmeyer M. Grab 3rd ed. Methods of Enzymatic Analysis vol. 6 1984 VCH New York 11 18
28. M. Kokai, S. Kashiwamura, H. Okamura, K. Ohara, and Y. Morita Plasma interleukin-18 levels in patients with psychiatric disorders J. Immunother. 25 Suppl 1 2002 S68 S71
29. T. Kraus, M. Haack, A. Schuld, D. Hinze-Selch, D. Koethe, and T. Pollmacher Body weight the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine Pharmacopsychiatry 35 2002 220 225
30. Z. Kronfol Immune dysregulation in major depression: a critical review of existing evidence Int. J. Neuropsychopharmacol. 5 2002 333 343
31. Z. Kronfol, and D.G. Remick Cytokines and the brain: implications for clinical psychiatry Am. J. Psychiatry 157 2000 683 694
32. S. Lanquillon, J.C. Krieg, U. Bening-Abu-Shach, and H. Vedder Cytokine production and treatment response in major depressive disorder Neuropsychopharmacology 22 2000 370 379
33. F. Lesperance, N. Frasure-Smith, P. Theroux, and M. Irwin The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes Am. J. Psychiatry 161 2004 271 277
34. J. Licinio, and M.L. Wong The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection Mol. Psychiatry 4 1999 317 327
35. J.M. Loftis, and P. Hauser The phenomenology and treatment of interferon-induced depression J. Affect. Disord. 82 2004 175 190
36. M. Maes, W. Stevens, L. DeClerck, C. Bridts, D. Peeters, C. Schotte, and P. Cosyns Immune disorders in depression: higher T helper/T suppressor-cytotoxic cell ratio Acta Psychiatr. Scand. 86 1992 423 431
37. M. Maes, H.Y. Meltzer, W. Stevens, J. Calabrese, and P. Cosyns Natural killer cell activity in major depression: relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology Prog. Neuropsychopharmacol. Biol. Psychiatry 18 1994 717 730
38. M. Maes, J. Lambrechts, E. Suy, C. Vandervorst, and E. Bosmans Absolute number and percentage of circulating natural killer, non-MHC-restricted T cytotoxic, and phagocytic cells in unipolar depression Neuropsychobiology 29 1994 157 163
39. M. Maes, H.Y. Meltzer, E. Bosmans, R. Bergmans, E. Vandoolaeghe, R. Ranjan, and R. Desnyder Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression J.Affect Disord. 34 1995 301 309
40. M. Maes, E. Vandoolaeghe, R. Ranjan, E. Bosmans, A. Van Gastel, R. Bergmans, and R. Desnyder Increased serum soluble CD8 or suppressor/cytotoxic antigen concentrations in depression: suppressive effects of glucocorticoids Biol Psychiatry 40 1996 1273 1281
41. K.Z. Matalka Neuroendocrine and cytokines-induced responses to minutes, hours and days of mental stress Neuro Endocrinol. Lett. 24 2003 283 292
42. O. Mikova, R. Yakimova, E. Bosmans, G. Kenis, and M. Maes Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis Eur. Neuropsychopharmacol. 11 2001 203 208
43. D.B. Miller, and P.O. O'Callaghan Neuroendocrine aspects of the response to stress Metabolism 51 2002 5 10
44. M.C. Mokrani, F. Duval, M.A. Crocq, P. Bailey, and J.P. Macher HPA axis dysfunction in depression: correlation with monoamine system abnormalities Psychoneuroendocrinology 22 1997 S63 S68
45. T.R. Mosmann, and S. Sad The expanding universe of T-cell subsets: Th1, Th2 and more Immunol. Today 17 1996 138 146
46. M. Olff Stress, depression and immunity: the role of defense and coping styles Psychiatry Res. 85 1999 7 15
47. B.M. Owen, D. Eccleston, I.N. Ferrier, and A.H. Young Raised levels of plasma interleukin-1beta in major and postviral depression Acta Psychiatr. Scand. 103 2001 226 228
48. L. Pace, C. Pioli, and G. Doria IL-4 modulation of CD4+CD25+ T regulatory cell-mediated suppression J. Immunol. 174 2005 7645 7653
49. K.J. Parker, A.F. Schatzberg, and D.M. Lyons Neuroendocrine aspects of hypercorticosolism in major depression Horm. Behav. 43 2003 60 66
50. E.W. Paul Fundamental Immunology 4th ed. 1998 Lippincott-Raven Publishers Philadelphia
51. B.W. Penninx, S.B. Kritchevsky, K. Yaffe, A.B. Newman, E.M. Simonsick, S. Rubin, L. Ferrucci, T. Harris, and M. Pahor Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study Biol. Psychiatry 54 2003 566 572
52. A.V. Ravindran, J. Griffiths, Z. Merali, and H. Anisman Lymphocyte subsets associated with major depression and dysthymia: modification by antidepressant treatment Psychosom. Med. 57 1995 555 563
53. A.V. Ravindran, J. Griffiths, Z. Merali, and H. Anisman Primary dysthymia: a study of several psychosocial, endocrine and immune correlates J. Affect. Disord. 40 1996 73 84
54. A.V. Ravindran, J. Griffiths, Z. Merali, and H. Anisman Circulating lymphocyte subsets in major depression and dysthymia with typical or atypical features Psychosom. Med. 60 1998 283 289
55. S. Romagnani Introduction: characterization and functions of human T regulatory cells Microbes Infect. 2005
56. G.A. Rook Glucocorticoids and immune function Baillieres Best Pract. Res. Clin. Endocrinol Metab. 4 1999 567 581
57. G.A.W. Rook, R. Hernández Pando, R. Baker, E.H. Orozco, K. Arriaga, L. Pavón, and M.L. Streber Human and murine tuberculosis as models for immuno-endocrine interactions G.A.W. Rook S. Lightman Steroid Hormones the T-cell Cytokine Profile 1997 Springer London 193 220
58. B. Ruzic, I. Tomaskovic, D. Trnski, O. Kraus, M. Bekavac-Beslin, and N. Vrkic Systemic stress responses in patients undergoing surgery for benign prostatic hyperplasia BJU Int. 95 2005 77 80
59. S.J. Schleifer, S.E. Keller, A.T. Meyerson, M.J. Raskin, K.L. Davis, and M. Stein Lymphocyte function in major depressive disorder Arch. Gen. Psychiatry 41 1984 484 486
60. S.J. Schleifer, S.E. Keller, and J.A. Bartlett Depression and immunity: clinical factors and therapeutic course Psychiatry Res. 85 1999 63 69
61. A. Schuld, D.A. Schmid, M. Haack, F. Holsboer, E. Friess, and T. Pollmacher Hypothalamopituitary-adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not with cytokine responses to hydrocortisone J. Psychiatr. Res. 37 2003 463 470
62. A. Seidel, V. Arolt, M. Hunstiger, L. Rink, A. Behnisch, and H. Kirchner Cytokine production and serum proteins in depression Scand. J. Immunol. 41 1995 534 538
63. A. Seidel, V. Arolt, M. Hunstiger, L. Rink, A. Behnisch, and H. Kirchner Increased CD56+ natural killer cells and related cytokines in major depression Clin. Immunol. Immunopathol. 78 1996 83 85
64. I. Souter, C. Janzen, O. Martinez-Maza, E.C. Breen, F. Stanczyk, G. Chaudhuri, and L. Nathan Serum levels of soluble vascular cell adhesion molecule-1 are decreased in women receiving oral contraceptives compared with normally menstruating women: implications in atherosclerosis Fertil. Steril. 83 2005 1480 1488
65. C. Tuglu, S.H. Kara, O. Caliyurt, E. Vardar, and E. Abay Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder Psychopharmacology 170 2003 429 433
66. R. Von Kanel, B.M. Kudielka, D. Preckel, D. Hanebuth, and J.E. Fischer Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men Brain Behav. Immun. 2005
67. E.P. Zorrilla, L. Luborsky, and J.R. McKay The relationship of depression and stressors to immunological assays: a meta-analytic review Brain Behav. Immun. 15 2001 199 226